UTHR Whale Insider Sales Explained: United Therapeutics CEO Flow in Late July 2026

UTHR whale insider sales are the loudest open-market Form 4 pattern on ProBors in late July 2026. In the last 14 days through July 27, 2026, UTHR ranks first on the whale leaderboard with 151 large prints, 111 open-market sales, zero purchases, and about $37 million in net reported selling. Most volume comes from CEO Martine Rothblatt filing roughly $5 million in code S sales on consecutive trade dates—not a one-day headline exit. CFO Paul Mahon contributed a separate $4.4 million cluster on July 16. This guide explains the daily sale rhythm, how to triage officer-led waves versus fund distributions, recent rows worth a second look, and what the whale board does not prove. It is research context, not investment advice.

Why UTHR tops the late-July 2026 whale board

United Therapeutics sits in a different insider-flow bucket than the disposition-heavy NUVL cluster or the Silver Lake distribution wave on DELL. Three patterns explain why UTHR leads the 14-day leaderboard ahead of CRWV and CPRX:

• Sustained CEO open-market sales dominate. Rothblatt filed code S sales on at least ten consecutive trade dates from July 13 through July 23, 2026, with each day totaling roughly $5 million split across eight to fourteen Form 4 lines.
• A second officer joined on one date. Mahon filed eight code S lines on July 16, 2026 totaling about $4.4 million, filed the same day—a separate bucket from Rothblatt's daily rhythm.
• Open-market purchases are absent at whale scale. The 14-day leaderboard shows zero buys on UTHR while sales account for 111 of 151 whale-class prints.

Whale leaderboards rank by print frequency and reported value. UTHR is loud because one CEO filed predictable daily tranches across two weeks—not because a dozen unrelated insiders exited at once.

Recent UTHR whale filings in ProBors

The table below shows deduplicated whale rows from ProBors as of July 27, 2026. Each row is the largest open-market sale (code S) per reporting owner and trade date in the recent filing window. Reported values are as indexed in ProBors; sales appear as positive dollar amounts for readability.

Filing lag here is mostly routine: one calendar day between trade and filing is common on Rothblatt's July 20–23 cluster. The July 17 trade filed July 20 shows a three-day gap—worth a footnote check on SEC EDGAR but still within a normal reporting window for a multi-line sale batch.

A five-step triage framework for officer-led whale waves

Use the same checklist when a biotech CEO tops the whale board through sustained open-market sales.

1. Read the SEC transaction code first

Open-market sales use code S. Option exercises (M), tax withholding (F), and grants (A) are different economic events. Rothblatt's July cluster is overwhelmingly code S—filter here before you lump exercise-and-sell mechanics into the same story.

2. Measure daily tranches, not individual lines

Ten to fourteen code S lines on July 23, 2026 totaling about $5.0 million are one distribution event split across tranches. Do not count each line as an independent bearish signal. Compare daily totals across the week: Rothblatt's July 13–23 daily clusters each land near $5 million, a pattern that often reflects a pre-scheduled plan rather than ad-hoc selling.

3. Separate CEO rhythm from one-off officer sales

Mahon's July 16 cluster is a separate research bucket from Rothblatt's daily cadence. A CFO sale on one date does not confirm or contradict a CEO's multi-week program—tag holder role before you merge narratives.

4. Compare to the 14-day whale leaderboard

UTHR at 151 prints and zero buys leads the current board by frequency. CRWV (150 prints) and CPRX (127 prints) follow, but CPRX and NUVL activity in this window is disposition-heavy—not open-market code S flow. Officer selling on a mature biotech reads differently than post-IPO fund distribution on CRWV. For leaderboard context, see top whale tickers in July 2026.

5. Cross-check congressional and chart context

Congressional PTR rows on UTHR are sparse and dated. ProBors shows Rep. Michael McCaul filed sales in 2025—not in the July 2026 insider window. No recent House or Senate PTR overlap confirms or contradicts the whale wave. Open the UTHR workspace on ProBors to compare price action, insider flow, and any politician markers on one chart.

How to research UTHR whale flow on ProBors

1. Open the Whales tab and filter by ticker UTHR.
2. Sort by filing date (newest first) to catch Rothblatt's latest daily tranche.
3. Read transaction codes and insider names before sorting by reported value—exercise rows can inflate the queue on the same trade dates.
4. Group rows by trade date and sum reported value to see whether daily totals follow a repeating pattern.
5. Note signal scores as a second sort. Scores of 5 flag attention on multi-million-dollar officer sales but do not prove bearish intent—read footnotes for 10b5-1 plan references on the original filing.
6. Switch to the Trades tab with the same ticker to see whether any House or Senate PTRs overlap your insider window.
7. Add UTHR to a watchlist if you want alerts when the next daily tranche arrives. See ProBors watchlist alerts for setup steps.

For broader whale triage habits, see how to triage whale transactions on ProBors.

What this does not prove

Sustained UTHR whale selling in late July 2026 does not prove:

• That United Therapeutics management expects weaker clinical or commercial results.
• That Rothblatt's daily $5 million cadence is discretionary rather than plan-driven—many officer sale programs follow pre-set schedules.
• That Mahon's July 16 cluster confirms the same thesis as the CEO's multi-week rhythm.
• That congressional PTR history from 2025 validates or contradicts current insider flow.
• That signal scores alone justify a trade—the scores prioritize research attention, not outcomes.

Form 4 disclosures document what was filed and when. They do not reveal motive, plan type, or whether a sale was tax-driven, estate planning, or pre-scheduled.

FAQ

Why does Rothblatt file roughly $5 million in sales every day?

Multi-line daily clusters near the same dollar total often reflect a Rule 10b5-1 trading plan or similar pre-scheduled program. ProBors indexes each Form 4 line separately, which inflates print count. Read the footnotes on the original filing before treating the rhythm as discretionary selling.

Is UTHR more "bearish" than NUVL on the whale board?

They answer different questions. NUVL dominated mid-July through billion-dollar disposition and tender codes—not open-market sales. UTHR leads late July through sustained code S officer flow. Compare transaction codes before ranking one ticker as more bearish. See NUVL whale insider dispositions explained for the disposition pattern.

Does Paul Mahon's July 16 sale change the CEO story?

It adds a second officer data point on one date but does not by itself confirm a company-wide exit. Mahon's $4.4 million cluster is smaller in duration than Rothblatt's two-week daily program—keep them in separate research buckets.

How does UTHR compare to DELL on the whale leaderboard?

DELL whale volume comes from private-equity fund entities distributing shares. UTHR volume comes from individual officers filing open-market code S sales. Fund mechanics and CEO programs require different triage lenses. See Dell whale insider sales explained.

Where do I verify a specific row?

Open the original Form 4 on SEC EDGAR — United Therapeutics search and compare trade date, transaction code, share count, and reporting owner to the ProBors row. Check probors.com/status if rows look stale.

Track UTHR insider and whale filings

Use ProBors to filter whale transactions by ticker, read signal scores, and compare insider flow with congressional disclosures on one workspace.

Get started

Related reading

• Top whale tickers in July 2026 — where UTHR ranks on the broader leaderboard
• How to triage whale transactions on ProBors — a repeatable framework for loud tickers
• NUVL whale insider dispositions explained — the disposition-and-tender counterpart
• ProBors whales tab guide — filters, codes, and sorting on the whale workspace

Sources

• SEC Form 4 overview — insider transaction reporting requirements
• SEC EDGAR — United Therapeutics Form 4 search
• SEC Rule 10b5-1 trading plans — context for pre-scheduled insider sales
• House STOCK Act disclosure information
• Rows were checked in ProBors and should be verified against the original filing. Ingestion health: probors.com/status.